48
Views
21
CrossRef citations to date
0
Altmetric
Miscellaneous

The use of α-adrenoceptor antagonists in lower urinary tract disease

Pages 167-172 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

P KS Sarma, Atul Tiwari & Arani Pal. (2005) α1-Adrenoceptors as potential therapeutic targets. Expert Opinion on Therapeutic Patents 15:10, pages 1333-1351.
Read now

Articles from other publishers (20)

Saret Dávila-Santacruz, Dora Luz Corona-Quintanilla, Verónica Velázquez-Orozco, Margarita Martínez-Gómez, Francisco Castelán, Estela Cuevas-Romero, Balduino Barrales-Fuentes, Leticia Nicolás-Toledo & Jorge Rodríguez-Antolín. (2024) Sucrose consumption modifies the urethrogenital reflex and histological organization of the bulbospongiosus muscle in the male rat. Physiology & Behavior 273, pages 114391.
Crossref
Dora Luz Corona-Quintanilla, Verónica Velázquez-Orozco, Irving Xicohténcatl-Rugerio, Omar Lara-García, Estela Cuevas, Margarita Martínez-Gómez, Leticia Nicolás Toledo & Jorge Rodríguez-Antolín. (2021) Sucrose exposure during gestation lactation and postweaning periods increases the pubococcygeus muscle reflex activity in adult male rats. International Journal of Impotence Research 34:6, pages 564-572.
Crossref
Liam King, David Christie, Wendy Dare, Nijole Bernaitis, Russ Chess-Williams, Catherine McDermott, Amanda Forbes & Shailendra Anoopkumar-Dukie. (2021) Quinazoline alpha-adrenoreceptor blockers as an adjunct cancer treatment: From bench to bedside. European Journal of Pharmacology 893, pages 173831.
Crossref
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 155 193 .
Larry Yet. 2018. Privileged Structures in Drug Discovery. Privileged Structures in Drug Discovery 59 82 .
Erica L. Reineke, Emily K. Thomas, Rebecca S. Syring, Jennifer Savini & Kenneth J. Drobatz. (2017) The effect of prazosin on outcome in feline urethral obstruction. Journal of Veterinary Emergency and Critical Care 27:4, pages 387-396.
Crossref
Amanda Forbes, Shailendra Anoopkumar-Dukie, Russ Chess-Williams & Catherine McDermott. (2016) Relative cytotoxic potencies and cell death mechanisms of α 1 -adrenoceptor antagonists in prostate cancer cell lines . The Prostate 76:8, pages 757-766.
Crossref
José Carlos Titos-Arcos, Hacibe Hallal, Raúl J. Andrade & Aurelio López Martín. (2011) Lesión hepatocelular recurrente por alfuzosina. Gastroenterología y Hepatología 34:2, pages 125-127.
Crossref
Seok Yeon KimByung-Ho KimSeok Ho DongHyo Jong KimYoung Woon ChnagRin ChangYoon Wha Kim. (2007) Alfuzosin-induced Acute Liver Injury. The Korean Journal of Hepatology 13:3, pages 414.
Crossref
Hao Fang, Min Yong Li & Lin Xia. (2007) Pharmacophore-guided design, synthesis and evaluation of quinazoline-arylpiperazines as new α1-adrenoceptor antagonists. Chinese Chemical Letters 18:1, pages 41-44.
Crossref
Jun Ha LeeHyo Sin KimJi Youl Lee. (2006) The Characteristics of Voiding Difficulty in Women and the Effect of Tamsulosin. Korean Journal of Urology 47:12, pages 1327.
Crossref
Min-Yong Li, Hao Fang & Lin Xia. (2005) Pharmacophore-based design, synthesis, biological evaluation, and 3D-QSAR studies of aryl-piperazines as α1-adrenoceptor antagonists. Bioorganic & Medicinal Chemistry Letters 15:13, pages 3216-3219.
Crossref
Min-Yong Li, Keng-Chang Tsai & Lin Xia. (2005) Pharmacophore identification of α1A-adrenoceptor antagonists. Bioorganic & Medicinal Chemistry Letters 15:3, pages 657-664.
Crossref
Ömer Faruk Yolcu, Seyfettin Köklü, Aydin Ş Köksal, Osman Yüksel, Yavuz Beyazit & Ömer Başar. (2004) Alfuzosin-Induced Acute Hepatitis in a Patient with Chronic Liver Disease. Annals of Pharmacotherapy 38:9, pages 1443-1445.
Crossref
VIPIN KUMAR & A. K. MADAN. (2011) TOPOLOGICAL MODEL FOR THE PREDICTION OF ALPHA-1 ADRENOCEPTOR ANTAGONISTIC ACTIVITY OF ARYLPIPERAZINES. Journal of Theoretical and Computational Chemistry 03:02, pages 245-255.
Crossref
R.S. Kirby, S. Quinn, S. Mallen & D. Jensen. (2004) Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis. International Journal of Clinical Practice 58:1, pages 6-10.
Crossref
George Katinas, Franz Halberg, Germaine Cornélissen, Kuniaki Otsuka, Roberto Tarquini, Federico Perfetto, Cristina Maggioni, Othild Schwartzkopff & Earl Bakken. (2003) Transient circadian hyper-amplitude-tension (CHAT) may be intermittent: case reports illustrating gliding spectral windows. Biomedicine & Pharmacotherapy 57, pages 104-109.
Crossref
Minyong Li, Lüpei Du, Bin Wu & Lin Xia. (2003) Self-organizing molecular field analysis on α1a-adrenoceptor dihydropyridine antagonists. Bioorganic & Medicinal Chemistry 11:18, pages 3945-3951.
Crossref
F.J. Lopez, L. Arias, R. Chan, D.E. Clarke, T.R. Elworthy, A.P.D.W. Ford, A. Guzman, S. Jaime-Figueroa, J.R. Jasper, D.J. MorgansJr.Jr., F. Padilla, A. Perez-Medrano, C. Quintero, M. Romero, L. Sandoval, S.A. Smith, T.J. Williams & D.R. Blue. (2003) Synthesis, pharmacology and pharmacokinetics of 3-(4-Aryl-piperazin-1-ylalkyl)-uracils as uroselective α1A-antagonists. Bioorganic & Medicinal Chemistry Letters 13:11, pages 1873-1878.
Crossref
R. Chess-Williams, S. Mason, D. J. Sellers, M. Wyllie & C. R. Chapple. (2002) The role of alpha1D-adrenoceptors in prostatic contraction examined using protection studies. Autonomic and Autacoid Pharmacology 22:5-6, pages 291-296.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.